nodes	percent_of_prediction	percent_of_DWPC	metapath
Flucloxacillin—Reaction gastrointestinal—Methotrexate—colon cancer	0.0258	0.0258	CcSEcCtD
Flucloxacillin—Heartburn—Fluorouracil—colon cancer	0.0241	0.0241	CcSEcCtD
Flucloxacillin—Oral candidiasis—Capecitabine—colon cancer	0.0182	0.0182	CcSEcCtD
Flucloxacillin—Appetite absent—Methotrexate—colon cancer	0.0173	0.0173	CcSEcCtD
Flucloxacillin—Colitis—Irinotecan—colon cancer	0.0166	0.0166	CcSEcCtD
Flucloxacillin—Throat sore—Capecitabine—colon cancer	0.016	0.016	CcSEcCtD
Flucloxacillin—Oropharyngeal discomfort—Capecitabine—colon cancer	0.0159	0.0159	CcSEcCtD
Flucloxacillin—Oropharyngeal pain—Capecitabine—colon cancer	0.0127	0.0127	CcSEcCtD
Flucloxacillin—Colitis—Capecitabine—colon cancer	0.0111	0.0111	CcSEcCtD
Flucloxacillin—Candida infection—Capecitabine—colon cancer	0.011	0.011	CcSEcCtD
Flucloxacillin—Neutropenia—Vincristine—colon cancer	0.0104	0.0104	CcSEcCtD
Flucloxacillin—Eosinophilia—Fluorouracil—colon cancer	0.0103	0.0103	CcSEcCtD
Flucloxacillin—Neutropenia—Irinotecan—colon cancer	0.0101	0.0101	CcSEcCtD
Flucloxacillin—Renal failure—Irinotecan—colon cancer	0.0095	0.0095	CcSEcCtD
Flucloxacillin—Jaundice—Irinotecan—colon cancer	0.00942	0.00942	CcSEcCtD
Flucloxacillin—Vascular purpura—Capecitabine—colon cancer	0.00939	0.00939	CcSEcCtD
Flucloxacillin—Haemolytic anaemia—Capecitabine—colon cancer	0.0093	0.0093	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Vincristine—colon cancer	0.0088	0.0088	CcSEcCtD
Flucloxacillin—Connective tissue disorder—Vincristine—colon cancer	0.00876	0.00876	CcSEcCtD
Flucloxacillin—Urethral disorder—Vincristine—colon cancer	0.00874	0.00874	CcSEcCtD
Flucloxacillin—Purpura—Capecitabine—colon cancer	0.00871	0.00871	CcSEcCtD
Flucloxacillin—Agranulocytosis—Fluorouracil—colon cancer	0.00864	0.00864	CcSEcCtD
Flucloxacillin—Connective tissue disorder—Irinotecan—colon cancer	0.00853	0.00853	CcSEcCtD
Flucloxacillin—Immune system disorder—Irinotecan—colon cancer	0.00784	0.00784	CcSEcCtD
Flucloxacillin—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.00756	0.00756	CcSEcCtD
Flucloxacillin—Anaemia—Vincristine—colon cancer	0.00717	0.00717	CcSEcCtD
Flucloxacillin—Bronchospasm—Capecitabine—colon cancer	0.00714	0.00714	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Irinotecan—colon cancer	0.00701	0.00701	CcSEcCtD
Flucloxacillin—Anaemia—Irinotecan—colon cancer	0.00698	0.00698	CcSEcCtD
Flucloxacillin—Leukopenia—Vincristine—colon cancer	0.00694	0.00694	CcSEcCtD
Flucloxacillin—Malaise—Irinotecan—colon cancer	0.00681	0.00681	CcSEcCtD
Flucloxacillin—Neutropenia—Capecitabine—colon cancer	0.00679	0.00679	CcSEcCtD
Flucloxacillin—Leukopenia—Irinotecan—colon cancer	0.00676	0.00676	CcSEcCtD
Flucloxacillin—Convulsion—Vincristine—colon cancer	0.00672	0.00672	CcSEcCtD
Flucloxacillin—Anaemia—Fluorouracil—colon cancer	0.00669	0.00669	CcSEcCtD
Flucloxacillin—Myalgia—Vincristine—colon cancer	0.0066	0.0066	CcSEcCtD
Flucloxacillin—Leukopenia—Fluorouracil—colon cancer	0.00648	0.00648	CcSEcCtD
Flucloxacillin—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00642	0.00642	CcSEcCtD
Flucloxacillin—Renal failure—Capecitabine—colon cancer	0.00636	0.00636	CcSEcCtD
Flucloxacillin—Discomfort—Irinotecan—colon cancer	0.00636	0.00636	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Vincristine—colon cancer	0.00633	0.00633	CcSEcCtD
Flucloxacillin—Jaundice—Capecitabine—colon cancer	0.00631	0.00631	CcSEcCtD
Flucloxacillin—Convulsion—Fluorouracil—colon cancer	0.00627	0.00627	CcSEcCtD
Flucloxacillin—Nervous system disorder—Vincristine—colon cancer	0.00621	0.00621	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Vincristine—colon cancer	0.0062	0.0062	CcSEcCtD
Flucloxacillin—Haematuria—Capecitabine—colon cancer	0.00617	0.00617	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Irinotecan—colon cancer	0.00617	0.00617	CcSEcCtD
Flucloxacillin—Myalgia—Fluorouracil—colon cancer	0.00616	0.00616	CcSEcCtD
Flucloxacillin—Hepatobiliary disease—Capecitabine—colon cancer	0.00612	0.00612	CcSEcCtD
Flucloxacillin—Discomfort—Fluorouracil—colon cancer	0.00609	0.00609	CcSEcCtD
Flucloxacillin—Nervous system disorder—Irinotecan—colon cancer	0.00605	0.00605	CcSEcCtD
Flucloxacillin—Agranulocytosis—Capecitabine—colon cancer	0.00604	0.00604	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Irinotecan—colon cancer	0.00604	0.00604	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Fluorouracil—colon cancer	0.00591	0.00591	CcSEcCtD
Flucloxacillin—Hepatitis—Capecitabine—colon cancer	0.00581	0.00581	CcSEcCtD
Flucloxacillin—Nervous system disorder—Fluorouracil—colon cancer	0.00579	0.00579	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Fluorouracil—colon cancer	0.00578	0.00578	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Vincristine—colon cancer	0.00577	0.00577	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Capecitabine—colon cancer	0.00574	0.00574	CcSEcCtD
Flucloxacillin—Connective tissue disorder—Capecitabine—colon cancer	0.00571	0.00571	CcSEcCtD
Flucloxacillin—Urethral disorder—Capecitabine—colon cancer	0.00569	0.00569	CcSEcCtD
Flucloxacillin—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.00563	0.00563	CcSEcCtD
Flucloxacillin—Decreased appetite—Vincristine—colon cancer	0.0055	0.0055	CcSEcCtD
Flucloxacillin—Erythema multiforme—Capecitabine—colon cancer	0.00549	0.00549	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Vincristine—colon cancer	0.00547	0.00547	CcSEcCtD
Flucloxacillin—Dyspepsia—Irinotecan—colon cancer	0.00543	0.00543	CcSEcCtD
Flucloxacillin—Constipation—Vincristine—colon cancer	0.00541	0.00541	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00538	0.00538	CcSEcCtD
Flucloxacillin—Decreased appetite—Irinotecan—colon cancer	0.00536	0.00536	CcSEcCtD
Flucloxacillin—Eosinophilia—Methotrexate—colon cancer	0.00535	0.00535	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Irinotecan—colon cancer	0.00532	0.00532	CcSEcCtD
Flucloxacillin—Constipation—Irinotecan—colon cancer	0.00527	0.00527	CcSEcCtD
Flucloxacillin—Immune system disorder—Capecitabine—colon cancer	0.00525	0.00525	CcSEcCtD
Flucloxacillin—Dyspepsia—Fluorouracil—colon cancer	0.0052	0.0052	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Vincristine—colon cancer	0.00518	0.00518	CcSEcCtD
Flucloxacillin—Decreased appetite—Fluorouracil—colon cancer	0.00513	0.00513	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Fluorouracil—colon cancer	0.0051	0.0051	CcSEcCtD
Flucloxacillin—Feeling abnormal—Irinotecan—colon cancer	0.00508	0.00508	CcSEcCtD
Flucloxacillin—Neutropenia—Methotrexate—colon cancer	0.00505	0.00505	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Irinotecan—colon cancer	0.00504	0.00504	CcSEcCtD
Flucloxacillin—Abdominal pain—Vincristine—colon cancer	0.00501	0.00501	CcSEcCtD
Flucloxacillin—Body temperature increased—Vincristine—colon cancer	0.00501	0.00501	CcSEcCtD
Flucloxacillin—Dysgeusia—Capecitabine—colon cancer	0.00495	0.00495	CcSEcCtD
Flucloxacillin—Abdominal pain—Irinotecan—colon cancer	0.00487	0.00487	CcSEcCtD
Flucloxacillin—Body temperature increased—Irinotecan—colon cancer	0.00487	0.00487	CcSEcCtD
Flucloxacillin—Feeling abnormal—Fluorouracil—colon cancer	0.00487	0.00487	CcSEcCtD
Flucloxacillin—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00478	0.00478	CcSEcCtD
Flucloxacillin—Renal failure—Methotrexate—colon cancer	0.00474	0.00474	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Capecitabine—colon cancer	0.00469	0.00469	CcSEcCtD
Flucloxacillin—Urticaria—Fluorouracil—colon cancer	0.00469	0.00469	CcSEcCtD
Flucloxacillin—Anaemia—Capecitabine—colon cancer	0.00467	0.00467	CcSEcCtD
Flucloxacillin—Body temperature increased—Fluorouracil—colon cancer	0.00467	0.00467	CcSEcCtD
Flucloxacillin—Hypersensitivity—Vincristine—colon cancer	0.00466	0.00466	CcSEcCtD
Flucloxacillin—Haematuria—Methotrexate—colon cancer	0.00459	0.00459	CcSEcCtD
Flucloxacillin—Malaise—Capecitabine—colon cancer	0.00456	0.00456	CcSEcCtD
Flucloxacillin—Hepatobiliary disease—Methotrexate—colon cancer	0.00456	0.00456	CcSEcCtD
Flucloxacillin—Hypersensitivity—Irinotecan—colon cancer	0.00454	0.00454	CcSEcCtD
Flucloxacillin—Leukopenia—Capecitabine—colon cancer	0.00453	0.00453	CcSEcCtD
Flucloxacillin—Agranulocytosis—Methotrexate—colon cancer	0.0045	0.0045	CcSEcCtD
Flucloxacillin—Hypersensitivity—Fluorouracil—colon cancer	0.00435	0.00435	CcSEcCtD
Flucloxacillin—Diarrhoea—Vincristine—colon cancer	0.00433	0.00433	CcSEcCtD
Flucloxacillin—Hepatitis—Methotrexate—colon cancer	0.00432	0.00432	CcSEcCtD
Flucloxacillin—Myalgia—Capecitabine—colon cancer	0.0043	0.0043	CcSEcCtD
Flucloxacillin—Arthralgia—Capecitabine—colon cancer	0.0043	0.0043	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00428	0.00428	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Methotrexate—colon cancer	0.00427	0.00427	CcSEcCtD
Flucloxacillin—Discomfort—Capecitabine—colon cancer	0.00425	0.00425	CcSEcCtD
Flucloxacillin—Urethral disorder—Methotrexate—colon cancer	0.00424	0.00424	CcSEcCtD
Flucloxacillin—Diarrhoea—Irinotecan—colon cancer	0.00422	0.00422	CcSEcCtD
Flucloxacillin—Dizziness—Vincristine—colon cancer	0.00419	0.00419	CcSEcCtD
Flucloxacillin—Erythema multiforme—Methotrexate—colon cancer	0.00409	0.00409	CcSEcCtD
Flucloxacillin—Dizziness—Irinotecan—colon cancer	0.00408	0.00408	CcSEcCtD
Flucloxacillin—Nervous system disorder—Capecitabine—colon cancer	0.00405	0.00405	CcSEcCtD
Flucloxacillin—Diarrhoea—Fluorouracil—colon cancer	0.00404	0.00404	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Capecitabine—colon cancer	0.00404	0.00404	CcSEcCtD
Flucloxacillin—Vomiting—Vincristine—colon cancer	0.00403	0.00403	CcSEcCtD
Flucloxacillin—Skin disorder—Capecitabine—colon cancer	0.00401	0.00401	CcSEcCtD
Flucloxacillin—Rash—Vincristine—colon cancer	0.00399	0.00399	CcSEcCtD
Flucloxacillin—Dermatitis—Vincristine—colon cancer	0.00399	0.00399	CcSEcCtD
Flucloxacillin—Headache—Vincristine—colon cancer	0.00397	0.00397	CcSEcCtD
Flucloxacillin—Vomiting—Irinotecan—colon cancer	0.00392	0.00392	CcSEcCtD
Flucloxacillin—Immune system disorder—Methotrexate—colon cancer	0.00391	0.00391	CcSEcCtD
Flucloxacillin—Dizziness—Fluorouracil—colon cancer	0.00391	0.00391	CcSEcCtD
Flucloxacillin—Rash—Irinotecan—colon cancer	0.00389	0.00389	CcSEcCtD
Flucloxacillin—Dermatitis—Irinotecan—colon cancer	0.00388	0.00388	CcSEcCtD
Flucloxacillin—Headache—Irinotecan—colon cancer	0.00386	0.00386	CcSEcCtD
Flucloxacillin—Nausea—Vincristine—colon cancer	0.00376	0.00376	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00376	0.00376	CcSEcCtD
Flucloxacillin—Vomiting—Fluorouracil—colon cancer	0.00375	0.00375	CcSEcCtD
Flucloxacillin—Rash—Fluorouracil—colon cancer	0.00372	0.00372	CcSEcCtD
Flucloxacillin—Dermatitis—Fluorouracil—colon cancer	0.00372	0.00372	CcSEcCtD
Flucloxacillin—Headache—Fluorouracil—colon cancer	0.0037	0.0037	CcSEcCtD
Flucloxacillin—Dysgeusia—Methotrexate—colon cancer	0.00369	0.00369	CcSEcCtD
Flucloxacillin—Nausea—Irinotecan—colon cancer	0.00366	0.00366	CcSEcCtD
Flucloxacillin—Dyspepsia—Capecitabine—colon cancer	0.00363	0.00363	CcSEcCtD
Flucloxacillin—Decreased appetite—Capecitabine—colon cancer	0.00359	0.00359	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Capecitabine—colon cancer	0.00356	0.00356	CcSEcCtD
Flucloxacillin—Constipation—Capecitabine—colon cancer	0.00353	0.00353	CcSEcCtD
Flucloxacillin—Nausea—Fluorouracil—colon cancer	0.00351	0.00351	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Methotrexate—colon cancer	0.00349	0.00349	CcSEcCtD
Flucloxacillin—Anaemia—Methotrexate—colon cancer	0.00348	0.00348	CcSEcCtD
Flucloxacillin—Feeling abnormal—Capecitabine—colon cancer	0.0034	0.0034	CcSEcCtD
Flucloxacillin—Malaise—Methotrexate—colon cancer	0.00339	0.00339	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Capecitabine—colon cancer	0.00337	0.00337	CcSEcCtD
Flucloxacillin—Leukopenia—Methotrexate—colon cancer	0.00337	0.00337	CcSEcCtD
Flucloxacillin—Urticaria—Capecitabine—colon cancer	0.00328	0.00328	CcSEcCtD
Flucloxacillin—Abdominal pain—Capecitabine—colon cancer	0.00326	0.00326	CcSEcCtD
Flucloxacillin—Body temperature increased—Capecitabine—colon cancer	0.00326	0.00326	CcSEcCtD
Flucloxacillin—Convulsion—Methotrexate—colon cancer	0.00326	0.00326	CcSEcCtD
Flucloxacillin—Arthralgia—Methotrexate—colon cancer	0.0032	0.0032	CcSEcCtD
Flucloxacillin—Myalgia—Methotrexate—colon cancer	0.0032	0.0032	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00318	0.00318	CcSEcCtD
Flucloxacillin—Discomfort—Methotrexate—colon cancer	0.00317	0.00317	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Methotrexate—colon cancer	0.00307	0.00307	CcSEcCtD
Flucloxacillin—Hypersensitivity—Capecitabine—colon cancer	0.00304	0.00304	CcSEcCtD
Flucloxacillin—Nervous system disorder—Methotrexate—colon cancer	0.00301	0.00301	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Methotrexate—colon cancer	0.00301	0.00301	CcSEcCtD
Flucloxacillin—Skin disorder—Methotrexate—colon cancer	0.00298	0.00298	CcSEcCtD
Flucloxacillin—Diarrhoea—Capecitabine—colon cancer	0.00282	0.00282	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.0028	0.0028	CcSEcCtD
Flucloxacillin—Dizziness—Capecitabine—colon cancer	0.00273	0.00273	CcSEcCtD
Flucloxacillin—Dyspepsia—Methotrexate—colon cancer	0.0027	0.0027	CcSEcCtD
Flucloxacillin—Decreased appetite—Methotrexate—colon cancer	0.00267	0.00267	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Methotrexate—colon cancer	0.00265	0.00265	CcSEcCtD
Flucloxacillin—Vomiting—Capecitabine—colon cancer	0.00262	0.00262	CcSEcCtD
Flucloxacillin—Rash—Capecitabine—colon cancer	0.0026	0.0026	CcSEcCtD
Flucloxacillin—Dermatitis—Capecitabine—colon cancer	0.0026	0.0026	CcSEcCtD
Flucloxacillin—Headache—Capecitabine—colon cancer	0.00259	0.00259	CcSEcCtD
Flucloxacillin—Feeling abnormal—Methotrexate—colon cancer	0.00253	0.00253	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Methotrexate—colon cancer	0.00251	0.00251	CcSEcCtD
Flucloxacillin—Nausea—Capecitabine—colon cancer	0.00245	0.00245	CcSEcCtD
Flucloxacillin—Urticaria—Methotrexate—colon cancer	0.00244	0.00244	CcSEcCtD
Flucloxacillin—Abdominal pain—Methotrexate—colon cancer	0.00243	0.00243	CcSEcCtD
Flucloxacillin—Body temperature increased—Methotrexate—colon cancer	0.00243	0.00243	CcSEcCtD
Flucloxacillin—Hypersensitivity—Methotrexate—colon cancer	0.00226	0.00226	CcSEcCtD
Flucloxacillin—Diarrhoea—Methotrexate—colon cancer	0.0021	0.0021	CcSEcCtD
Flucloxacillin—Dizziness—Methotrexate—colon cancer	0.00203	0.00203	CcSEcCtD
Flucloxacillin—Vomiting—Methotrexate—colon cancer	0.00195	0.00195	CcSEcCtD
Flucloxacillin—Rash—Methotrexate—colon cancer	0.00194	0.00194	CcSEcCtD
Flucloxacillin—Dermatitis—Methotrexate—colon cancer	0.00194	0.00194	CcSEcCtD
Flucloxacillin—Headache—Methotrexate—colon cancer	0.00192	0.00192	CcSEcCtD
Flucloxacillin—Nausea—Methotrexate—colon cancer	0.00182	0.00182	CcSEcCtD
